<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.exac.com/news/news-1/RSS">
  <title>News</title>
  <link>http://www.exac.com</link>
  
  <description>
    
       News
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2007-11-26T15:37:37Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.exac.com/logo.jpg"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-initiates-multi-center-clinical-trial-for-new-cartilage-regeneration-technology"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-continues-to-expand-spine-portfolio-with-comprehensive-solution-to-posterior-cervical-fusion"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-announces-agreement-with-u.s.-attorney2019s-office.-voluntarily-extends-term-of-deferred-prosecution-agreement-for-three-months"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-q3-revenue-up-13-to-47.3m-driven-by-robust-international-growth.-net-income-1.3m-or-0.10-eps"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-schedules-third-quarter-2011-earnings-release-and-conference-call"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-ceo-dr.-bill-petty-will-appear-on-cnbc2019s-kudlow-report-tonight-monday-7-2013-8-pm"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-introduces-new-material-efficient-approach-for-acetabular-reconstruction"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-to-present-at-canaccord-genuity-investor-conference"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/arthritis-patient-helped-create-innovative-knee-implant-that-restored-his-active-lifestyle"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-q2-revenue-up-9-to-51.7m-net-income-2.7m-eps-0.21-driven-by-strong-international-growth"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-schedules-second-quarter-2011-earnings-release-and-conference-call"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-continues-to-expand-spine-portfolio-through-first-internally-developed-product"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-to-present-at-the-2011-noble-financial-equity-conference-on-may-16"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-q1-revenue-up-9-to-53.4m-net-income-3.0m-with-strong-performance-in-hip-and-extremity-products"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-announces-full-market-release-of-the-equinoxeae-shoulder-fracture-plate"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.exac.com/news/exactech-initiates-multi-center-clinical-trial-for-new-cartilage-regeneration-technology">        <title>Exactech Initiates Multi-Center Clinical Trial for New Cartilage Regeneration Technology</title>        <link>http://www.exac.com/news/exactech-initiates-multi-center-clinical-trial-for-new-cartilage-regeneration-technology</link>        <description>December 19, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials announced today it has initiated a prospective, randomized, multi-center, clinical trial to evaluate the safety and effectiveness of a new cartilage repair technology.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-12-19T16:19:23Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-continues-to-expand-spine-portfolio-with-comprehensive-solution-to-posterior-cervical-fusion">        <title>Exactech Continues to Expand Spine Portfolio with Comprehensive Solution to Posterior Cervical Fusion</title>        <link>http://www.exac.com/news/exactech-continues-to-expand-spine-portfolio-with-comprehensive-solution-to-posterior-cervical-fusion</link>        <description>GAINESVILLE, FL – Dec 08, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced the full market launch of its Gibralt® spinal system at the Cervical Spine Research Society Annual Meeting this week. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-12-08T21:01:54Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-announces-agreement-with-u.s.-attorney2019s-office.-voluntarily-extends-term-of-deferred-prosecution-agreement-for-three-months">        <title>Exactech Announces Agreement with U.S. Attorney’s Office. Voluntarily Extends Term of Deferred Prosecution Agreement for Three Months</title>        <link>http://www.exac.com/news/exactech-announces-agreement-with-u.s.-attorney2019s-office.-voluntarily-extends-term-of-deferred-prosecution-agreement-for-three-months</link>        <description>GAINESVILLE, Fla. – December 07, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it agreed to enter into an amendment to its Deferred Prosecution Agreement (DPA) with the United States Attorney’s Office for the District of New Jersey (USAO) that extends the term of the DPA for three months, ending on March 8, 2012.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-12-08T14:38:14Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-q3-revenue-up-13-to-47.3m-driven-by-robust-international-growth.-net-income-1.3m-or-0.10-eps">        <title>Exactech Q3 Revenue Up 13% to $47.3M Driven by Robust International Growth. Net Income $1.3M or $0.10 EPS</title>        <link>http://www.exac.com/news/exactech-q3-revenue-up-13-to-47.3m-driven-by-robust-international-growth.-net-income-1.3m-or-0.10-eps</link>        <description>Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $47.3 million for the third quarter of 2011, a 13% increase over $42.0 million in the third quarter of 2010. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-11-04T15:03:22Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-schedules-third-quarter-2011-earnings-release-and-conference-call">        <title>Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call</title>        <link>http://www.exac.com/news/exactech-schedules-third-quarter-2011-earnings-release-and-conference-call</link>        <description>Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its third quarter 2011 financial results on November 1, 2011. A copy of the earnings release will be available at http://www.hawkassociates.com.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-10-18T15:12:35Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-ceo-dr.-bill-petty-will-appear-on-cnbc2019s-kudlow-report-tonight-monday-7-2013-8-pm">        <title>Exactech CEO Dr. Bill Petty appeared on CNBC’s Kudlow Report on Monday, Oct. 17 </title>        <link>http://www.exac.com/news/exactech-ceo-dr.-bill-petty-will-appear-on-cnbc2019s-kudlow-report-tonight-monday-7-2013-8-pm</link>        <description>Exactech CEO Dr. Bill Petty was interviewed for the Kudlow Report on Monday, Oct. 17. Exactech was highlighted as a middle market company that is managing better than many in this difficult economic climate. Dr. Petty answered questions about Exactech’s performance and the potential impact of proposed healthcare reform initiatives on the company, its customers and ultimately patients.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-10-18T13:56:47Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-introduces-new-material-efficient-approach-for-acetabular-reconstruction">        <title>Exactech Introduces New Material, Efficient Approach for Acetabular Reconstruction</title>        <link>http://www.exac.com/news/exactech-introduces-new-material-efficient-approach-for-acetabular-reconstruction</link>        <description>Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, reported today the first implantations of its new porous metal acetabular system and novel surgical technique designed to improve the initial stability and long-term biological fixation of hip replacement implants.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-09-21T15:10:57Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-to-present-at-canaccord-genuity-investor-conference">        <title>Exactech To Present at Canaccord Genuity Investor Conference</title>        <link>http://www.exac.com/news/exactech-to-present-at-canaccord-genuity-investor-conference</link>        <description>GAINESVILLE, Fla. – August 9, 2011 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials will present at the 2011 Canaccord Genuity Growth Conference in Boston on August 11.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-08-10T17:18:36Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/arthritis-patient-helped-create-innovative-knee-implant-that-restored-his-active-lifestyle">        <title>Arthritis Patient Helped Create Innovative Knee Implant That Restored His Active Lifestyle</title>        <link>http://www.exac.com/news/arthritis-patient-helped-create-innovative-knee-implant-that-restored-his-active-lifestyle</link>        <description>GAINESVILLE, Fla. (Monday, Aug. 8) – Kevin Hindle, a 47-year-old manufacturing engineer at Exactech, Inc., a global orthopaedic device company, regained his active lifestyle with an innovative new knee implant that he helped develop.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-08-10T19:10:58Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-q2-revenue-up-9-to-51.7m-net-income-2.7m-eps-0.21-driven-by-strong-international-growth">        <title>Exactech Q2 Revenue Up 9% to $51.7M, Net Income $2.7M, EPS $0.21 Driven by Strong International Growth</title>        <link>http://www.exac.com/news/exactech-q2-revenue-up-9-to-51.7m-net-income-2.7m-eps-0.21-driven-by-strong-international-growth</link>        <description>GAINESVILLE, Fla. – August 2, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $51.7 million for the second quarter of 2011, a 9% increase over $47.6 million in the second quarter of 2010. Net income decreased 9% to $2.7 million, or $0.21 per diluted share, compared to $3.0 million, or $0.23 per diluted share, in the same quarter a year ago. Net income for the quarter, excluding Health Care Professional (HCP) compliance expenses of $1.5 million related to the Department of Justice (DOJ) settlement, increased 13% to $3.7 million or $0.28 EPS.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-08-02T21:06:31Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-schedules-second-quarter-2011-earnings-release-and-conference-call">        <title>Exactech Schedules Second Quarter 2011 Earnings Release and Conference Call</title>        <link>http://www.exac.com/news/exactech-schedules-second-quarter-2011-earnings-release-and-conference-call</link>        <description>GAINESVILLE, Fla. – July 20, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter 2011 financial results on August 2, 2011. A copy of the earnings release will be
available at http://www.hawkassociates.com.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>mindy.underberger@exac.com</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-08-01T20:19:08Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-continues-to-expand-spine-portfolio-through-first-internally-developed-product">        <title>Exactech Continues to Expand Spine Portfolio Through First Internally-Developed Product</title>        <link>http://www.exac.com/news/exactech-continues-to-expand-spine-portfolio-through-first-internally-developed-product</link>        <description>GAINESVILLE, Fla. – May 31, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company’s Exactech Spine division has launched the Proliant™ Polyaxial Pedicle Screw System for orthopaedic and neurosurgeons. This product launch represents the first spinal system developed in-house by Exactech. The company established its spinal division with two acquisitions over the past three years.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>lnorthsea</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-05-31T13:34:54Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-to-present-at-the-2011-noble-financial-equity-conference-on-may-16">        <title>Exactech to Present at the 2011 Noble Financial Equity Conference on May 16</title>        <link>http://www.exac.com/news/exactech-to-present-at-the-2011-noble-financial-equity-conference-on-may-16</link>        <description></description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>lnorthsea</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-05-12T13:49:14Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-q1-revenue-up-9-to-53.4m-net-income-3.0m-with-strong-performance-in-hip-and-extremity-products">        <title>Exactech Q1 Revenue Up 9% to $53.4M, Net Income $3.0M With Strong Performance in Hip and Extremity Products</title>        <link>http://www.exac.com/news/exactech-q1-revenue-up-9-to-53.4m-net-income-3.0m-with-strong-performance-in-hip-and-extremity-products</link>        <description>GAINESVILLE, Fla. – May 3, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $53.4 million for the first quarter of 2011, a 9% increase over $49.1 million in the first quarter of 2010. Net income was $3.0 million, or $0.22 per diluted share, compared to $3.3 million, or $0.25 per diluted share, in the same quarter a year ago. Net income for the quarter, excluding pre-tax legal expenses and costs of $1.3 million related to ongoing compliance and monitoring costs associated with the Department of Justice (DOJ) settlement in December 2010, was $3.8 million or $0.28 EPS.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>lnorthsea</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-05-03T20:32:24Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-announces-full-market-release-of-the-equinoxeae-shoulder-fracture-plate">        <title>Exactech Announces Full Market Release of the Equinoxe® Shoulder Fracture Plate</title>        <link>http://www.exac.com/news/exactech-announces-full-market-release-of-the-equinoxeae-shoulder-fracture-plate</link>        <description>GAINESVILLE, Fla. – April 28, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it is fully launching the Equinoxe® Fx Plate, the latest addition to Exactech’s fast-growing Equinoxe® Platform Shoulder System.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>lnorthsea</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2011-04-28T14:23:42Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>

